Cerebral Protective Effect of Carbamylated Erythropoietin on Epileptic Model Mice

Yin-Hong QIU,Guo-Xing ZHU,Jing DING,Bao-Guo XIAO,Zheng HONG,Wei-Mao PANG,Fa-Ming WANG
DOI: https://doi.org/10.3969/j.issn.1008-0678.2011.03.015
2011-01-01
Abstract:Aim: To explore the protective effect of carbamylated erythropoietin on hippocampus neurons in the C57/B6 mice with status convulsion. Methods: The mice were randomly divided into three groups: normal group, CEPO-treated group, and saline(NS)-treated group. The status convulsion model was produced by pilocarpine in the latter two groups. In CEPO-treated group, CEPO was administered intraperitoneally at 2 hours before status convulsion, 2 and 24 hours after convulsion, while NS was injected instead at the same time points in NS-treated group. NeuN immunohistochemical staining was applied to evaluate neuron loss in the hippocampal CA1, CA2, CA3 and CA4 regions of the mice. The mortality, the latency of status convulsion and hippocampal cell loss were observed and compared among the groups. Results: There was no significant difference in mortality between CEPO and NS-treated groups. However, the latency of status convulsion produced by pilocarpine in CEPO-treated group were longer than that in NS-treated group(P<0.01). In addition, the NeuN immunohistochemistry demonstrated that neuron loss in hippocampus in CEPO group was significantly less compared with NS-treated group. Conclusion: CEPO can reduce the neuron apoptosis in the hippocampal after status convulsion in C57/B6 mice, which implies that CEPO might have the anti-apoptosis effect.
What problem does this paper attempt to address?